|Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas|
H Brem, S Piantadosi, PC Burger, M Walker, R Selker, NA Vick, K Black, ...
The Lancet 345 (8956), 1008-1012, 1995
|Tumor angiogenesis: a quantitative method for histologic grading|
S Brem, R Cotran, J Folkman
Journal of the National Cancer Institute 48 (2), 347-356, 1972
|Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End …|
FG Davis, S Freels, J Grutsch, S Barlas, S Brem
Journal of neurosurgery 88 (1), 1-10, 1998
|Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial|
R Stupp, S Taillibert, A Kanner, W Read, DM Steinberg, B Lhermitte, ...
Jama 318 (23), 2306-2316, 2017
|A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma|
DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ...
Science translational medicine 9 (399), 2017
|A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant …|
EA Chiocca, KM Abbed, S Tatter, DN Louis, FH Hochberg, F Barker, ...
Molecular Therapy 10 (5), 958-966, 2004
|A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme|
MR Rosenfeld, X Ye, JG Supko, S Desideri, SA Grossman, S Brem, ...
Autophagy 10 (8), 1359-1368, 2014
|Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.|
SS Brem, D Zagzag, AM Tsanaclis, S Gately, MP Elkouby, SE Brien
The American journal of pathology 137 (5), 1121, 1990
|Prolonged tumor dormancy by prevention of neovascularization in the vitreous|
S Brem, H Brem, J Folkman, D Finkelstein, A Patz
Cancer research 36 (8), 2807-2812, 1976
|Angiogenesis as a marker of preneoplastic lesions of the human breast|
SS Brem, HM Jensen, PM Gullino
Cancer 41 (1), 239-244, 1978
|Angiogenesis and cancer control: from concept to therapeutic trial|
Cancer Control 6 (5), 1-18, 1999
|Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia|
SS Brem, PM Gullino, D Medina
Science 195 (4281), 880-882, 1977
|Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and …|
GA Soff, J Sanderowitz, S Gately, E Verrusio, I Weiss, S Brem, HC Kwaan
The Journal of clinical investigation 96 (6), 2593-2600, 1995
|Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase …|
S Takano, S Gately, ME Neville, WF Herblin, JL Gross, H Engelhard, ...
Cancer research 54 (10), 2654-2660, 1994
|Inhibition of neovascularization by an extract derived from vitreous|
S Brem, I Preis, R Langer, H Brem, J Folkman, A Patz
American journal of ophthalmology 84 (3), 327-328, 1977
|The role of vascular proliferation in the growth of brain tumors.|
Clinical neurosurgery 23, 440-453, 1976
|Terson's syndrome: a reversible cause of blindness following subarachnoid hemorrhage|
AM Garfinkle, IR Danys, DA Nicolle, ART Colohan, S Brem
Journal of neurosurgery 76 (5), 766-771, 1992
|Inhibition of angiogenesis by Aβ peptides|
D Paris, K Townsend, A Quadros, J Humphrey, J Sun, S Brem, ...
Angiogenesis 7 (1), 75-85, 2004
|Central nervous system cancers|
SS Brem, PJ Bierman, H Brem, N Butowski, MC Chamberlain, EA Chiocca, ...
Journal of the National Comprehensive Cancer Network 9 (4), 352-400, 2011
|First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma|
LM Liau, K Ashkan, DD Tran, JL Campian, JE Trusheim, CS Cobbs, ...
Journal of translational medicine 16 (1), 1-9, 2018